161 related articles for article (PubMed ID: 19850648)
1. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
[TBL] [Abstract][Full Text] [Related]
2. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Malde B; Regalado J; Greenberger PA
Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease.
Imaizumi S; Miura S; Nishikawa H; Iwata A; Zhang B; Kawamura A; Tsuchiya Y; Kumagai K; Matsuo K; Saku K
Hypertens Res; 2006 Mar; 29(3):135-41. PubMed ID: 16755148
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
Nikaido A; Tada T; Nakamura K; Murakami M; Banba K; Nishii N; Fuke S; Nagase S; Sakuragi S; Morita H; Ohe T; Kusano KF
Int J Cardiol; 2010 Apr; 140(3):328-35. PubMed ID: 19106010
[TBL] [Abstract][Full Text] [Related]
6. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
7. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
9. Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.
Kheterpal S; Khodaparast O; Shanks A; O'Reilly M; Tremper KK
J Cardiothorac Vasc Anesth; 2008 Apr; 22(2):180-6. PubMed ID: 18375317
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
11. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme as a possible marker for lung toxicity in amiodarone-treated patients.
Foresti V; Pepe R; Parisio E; De Filippi G; Scolari N; Frigerio C
Int J Clin Pharmacol Res; 1989; 9(4):261-7. PubMed ID: 2550378
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
Ulrik CS; Aldershvile J
Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
[TBL] [Abstract][Full Text] [Related]
15. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).
Andraws R; Brown DL
Am J Cardiol; 2007 Apr; 99(7):1006-12. PubMed ID: 17398202
[TBL] [Abstract][Full Text] [Related]
17. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
18. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
Tiwari A; Tseng CL; Kern EF; Maney M; Miller DR; Pogach L
Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on the rate of new-onset diabetes mellitus: a review and pooled analysis.
McCall KL; Craddock D; Edwards K
Pharmacotherapy; 2006 Sep; 26(9):1297-306. PubMed ID: 16945052
[TBL] [Abstract][Full Text] [Related]
20. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
Gotsman I; Rubonivich S; Azaz-Livshits T
Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
